SHIP-1 Deficiency in AID + B Cells Leads to the Impaired Function of B10 Cells with Spontaneous Autoimmunity

Unlike conventional B cells, regulatory B cells exhibit immunosuppressive functions to downregulate inflammation via IL-10 production. However, the molecular mechanism regulating the production of IL-10 is not fully understood. In this study, we report the finding that activation-induced cytidine de...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of immunology (1950) Vol. 199; no. 9; pp. 3063 - 3073
Main Authors: Chen, Yingjia, Hu, Fanlei, Dong, Xuejiao, Zhao, Meng, Wang, Jing, Sun, Xiaolin, Kim, Tae Jin, Li, Zhanguo, Liu, Wanli
Format: Journal Article
Language:English
Published: United States American Association of Immunologists 01-11-2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Unlike conventional B cells, regulatory B cells exhibit immunosuppressive functions to downregulate inflammation via IL-10 production. However, the molecular mechanism regulating the production of IL-10 is not fully understood. In this study, we report the finding that activation-induced cytidine deaminase (AID) is highly upregulated in the IL-10-competent B cell (B10) cell from Innp5d Aicda mice, whereas the 5' inositol phosphatase SHIP-1 is downregulated. Notably, SHIP-1 deficiency in AID B cells leads to a reduction in cell count and impaired IL-10 production by B10 cells. Furthermore, the Innp5d Aicda mouse model shows B cell-dependent autoimmune lupus-like phenotypes, such as elevated IgG serum Abs, formation of spontaneous germinal centers, production of anti-dsDNA and anti-nuclear Abs, and the obvious deposition of IgG immune complexes in the kidney with age. We observe that these lupus-like phenotypes can be reversed by the adoptive transfer of B10 cells from control Innp5d mice, but not from the Innp5d Aicda mice. This finding highlights the importance of defective B10 cells in Innp5d Aicda mice. Whereas p-Akt is significantly upregulated, MAPK and AP-1 activation is impaired in B10 cells from Innp5d Aicda mice, resulting in the reduced production of IL-10. These results show that SHIP-1 is required for the maintenance of B10 cells and production of IL-10, and collectively suggests that SHIP-1 could be a new potential therapeutic target for the treatment of autoimmune diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-1767
1550-6606
DOI:10.4049/jimmunol.1700138